Zenas BioPharma, Inc. (ZBIO) Current Reports & Earnings Releases
Upcoming
- 2026-11-11 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-05-13 | 8-K | Results of Operations, Officer / Director Changes, Shareholder Vote Results, Financial Statements & Exhibits | SEC |
| 2026-03-31 | 8-K | Material Agreement, Direct Financial Obligation, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-16 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-02-13 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2026-01-05 | 8-K | Results of Operations, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-15 | 8-K | Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-10-27 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-10-08 | 8-K | Material Agreement, Results of Operations, Unregistered Sales, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2025-09-02 | 8-K | Material Agreement, Acquisition or Disposition, Direct Financial Obligation, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-06-12 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2025-06-04 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-05-15 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-02-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-12-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-11-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-09-16 | 8-K | Charter Amendments, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.